"The major innovation of this schema over previous ones, e.g. the WHO/ISFC 1995 classification, was an increasing orientation towards genetic information. However newer schemas include even more molecular and genetic information 1."
"cardiomyopathies from ion channelopathies (e.g. long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, short QT syndrome)"
"cardiomyopathies from ion channelopathies (e.g. long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, short QT syndrome)"
"Loeffler endocarditis"
"Friedreich ataxia"
"cardiomyopathies from ion channelopathies (e.g. long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, short QT syndrome)"
"systemic glycogen storage disease (e.g. Pompe disease)"